Gensight Biologics Sa Stock Annual Yield
| SIGHT Stock | EUR 0.28 0.01 3.70% |
Gensight Biologics SA fundamentals help investors to digest information that contributes to Gensight Biologics' financial success or failures. It also enables traders to predict the movement of Gensight Stock. The fundamental analysis module provides a way to measure Gensight Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gensight Biologics stock.
Gensight |
Gensight Biologics SA Company Annual Yield Analysis
Gensight Biologics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Gensight Biologics SA has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all France stocks average (which is currently at 0.0).
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Gensight Fundamentals
| Return On Equity | -1.72 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (6.59) % | |||
| Current Valuation | 150.19 M | |||
| Shares Outstanding | 46.16 M | |||
| Shares Owned By Insiders | 12.75 % | |||
| Shares Owned By Institutions | 35.65 % | |||
| Price To Book | 50.99 X | |||
| Price To Sales | 33.81 X | |||
| Revenue | 5.28 M | |||
| Gross Profit | 7.71 M | |||
| EBITDA | (25.52 M) | |||
| Net Income | (28.62 M) | |||
| Cash And Equivalents | 44.29 M | |||
| Cash Per Share | 1.06 X | |||
| Total Debt | 12.1 M | |||
| Debt To Equity | 14.40 % | |||
| Current Ratio | 3.65 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (17.14 M) | |||
| Earnings Per Share | (0.68) X | |||
| Target Price | 9.8 | |||
| Number Of Employees | 44 | |||
| Beta | 2.16 | |||
| Market Capitalization | 144.58 M | |||
| Total Asset | 56.65 M | |||
| Z Score | 6.6 | |||
| Net Asset | 56.65 M |
About Gensight Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gensight Biologics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gensight Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gensight Biologics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.